# A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

> **NCT00576108** · PHASE2 · COMPLETED · sponsor: **Kalypsys, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Postherpetic Neuralgia
- Shingles
- Herpes Zoster
- Neuropathic Pain

## Interventions

- **DRUG:** KD7040 Topical Gel
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT00576108
- **Lead sponsor:** Kalypsys, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2008-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576108, "A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00576108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*